Transchem publishes September 2026 quarter and half-year results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹412.05

prior close

₹414.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 173sector-0.3%+2.3% vs sector

On the reaction day the stock moved 2.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

-0.5

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9pendingpending-0.3+2.3

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Transchem published newspaper advertisements of its unaudited results for the quarter and half-year ended 30 September 2026. Company-only quarterly revenue was Rs 396.28 lakh and profit after tax Rs 202.65 lakh, versus Rs 167.62 lakh and Rs 67.92 lakh a year earlier. Group revenue was Rs 506.89 lakh and profit Rs 205.13 lakh. Half-year group profit was Rs 547.24 lakh. The results also note the Rs 26.02 crore sale of Galaxy Surfactants.

Likely market impact

Profit was higher year on year but below the June quarter. The Galaxy Surfactants sale adds a one-off element, so the share reaction may be mixed.